Subject(s)
COVID-19/diagnosis , Stevens-Johnson Syndrome/diagnosis , Adrenal Cortex Hormones/therapeutic use , Androstadienes/therapeutic use , Aromatase Inhibitors/therapeutic use , Body Surface Area , Bone Neoplasms/complications , Bone Neoplasms/drug therapy , Bone Neoplasms/secondary , Brain Neoplasms/complications , Brain Neoplasms/drug therapy , Brain Neoplasms/secondary , Breast Neoplasms/complications , Breast Neoplasms/drug therapy , Breast Neoplasms/pathology , COVID-19/complications , Dexamethasone/therapeutic use , Emollients/therapeutic use , Female , Hospitalization , Humans , Liver Neoplasms/complications , Liver Neoplasms/drug therapy , Liver Neoplasms/secondary , Middle Aged , Palliative Care , SARS-CoV-2 , Stevens-Johnson Syndrome/drug therapy , Stevens-Johnson Syndrome/etiology , Stevens-Johnson Syndrome/pathologyABSTRACT
A 65-year-old gentleman with a previous history of pulmonary embolus presented with a subacute onset of shortness of breath, haemoptysis and chest pain associated with a swollen left leg. Ultrasound Doppler scanning of the leg revealed no deep-vein thrombosis. Thereafter, a CT scan of the pulmonary vasculature revealed a large right-sided pulmonary embolus. CT scanning of the abdomen and pelvis was performed to look for evidence of an intra-abdominal source of thrombus and revealed evidence of a moderate sized pelvic mass causing obstructive uropathy. Urological review of the patient revealed a hard prostate and raised prostate specific antigen, consistent with a diagnosis of primary prostatic carcinoma, which after investigation with a radioisotope bone scan was found to have metastasised to the bony pelvis.
